Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

Name: Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.
License: Public Domain

Huazhong University of Science and Technology

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

t2dm

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 238312
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.